SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001683168-21-001014
Filing Date
2021-03-22
Accepted
2021-03-22 13:09:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G safranek_13g.htm SC 13G 46603
  Complete submission text file 0001683168-21-001014.txt   47943
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Subject) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-40457 | Film No.: 21760796
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3508 POPPLETON AVE OMAHA NE 58105
Business Address
SAFRANEK JOHN (Filed by) CIK: 0001852642 (see all company filings)

Type: SC 13G